English, Article edition: Cost Implications for the Use of Inhaled Anti-Inflammatory Medications in the Treatment of Asthma Ronald J. Ozminkowski; Shaohung Wang; William D. Marder; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/94589
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost Implications for the Use of Inhaled Anti-Inflammatory Medications in the Treatment of Asthma
Author
  • Ronald J. Ozminkowski
  • Shaohung Wang
  • William D. Marder
  • John Azzolini
  • David Schutt
Physical Description
  • article
Notes
  • Objective: To compare the expected costs of treating patients with asthma with versus without inhaled anti-inflammatory medications, adjusting for other factors that also influence medical care expenditures. Design: Nonlinear exponential regression analyses were used to estimate relationships between medical care expenditures and treatment with inhaled corticosteroids, sodium cromoglycate (cromolyn) or nedocromil. The regressions adjusted for differences in patients' demographics, location, plan type and severity of illness. Setting: Large, self-insured, corporate-sponsored medical plans represented in MarketScan database. Patients and Participants: 7466 continuously enrolled patients with asthma. Interventions: Treatment with inhaled corticosteroids, sodium cromoglycate or nedocromil. Main Outcome Measures: 1. Total inpatient, outpatient and pharmaceutical expenditures; and 2. asthma-related expenditures in the 1996 calendar year. Results: If all patients had been treated with inhaled anti-inflammatory drugs, total expenditures would be expected to be about $US944.82 per patient lower, on average, than would be the case if no patients received these drugs. Asthma-related expenditures would be about $US498.74 per patient higher, on average, if all patients were treated with these drugs. Conclusions: Using inhaled anti-inflammatory agents would be associated with higher asthma-related expenditures but lower total expenditures. Treatment with inhaled anti-inflammatory drugs may represent an investment in better care that pays off with better health and lower total medical care expenditures.
  • Antiasthmatics, Asthma, Corticosteroids, Cost analysis, Nedocromil, Pharmacoeconomics, Sodium cromoglycate
  • RePEc:wkh:phecon:v:18:y:2000:i:3:p:253-264
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment